{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-184871","form_type":"8-K","ticker":"ZYME","cik":"0001937653","company_name":"Zymeworks Inc.","filed_at":"2024-07-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.232031+00:00","generated_at":"2026-05-31T16:23:25.146589+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Zymeworks appoints Leone Patterson as EVP, Chief Business & CFO effective Sept 1, 2024","bullets":["Ms. Patterson appointed EVP, Chief Business Officer and CFO; start date Sept 1, 2024.","Kenneth Galbraith to step down as interim CFO but remain Chair and CEO.","Compensation: $485K base salary, 45% bonus target, $50K signing bonus, 360,000 inducement stock options.","Amended Inducement Plan increases share reserve by 700,000 shares to 1,450,000 total since plan inception.","Ms. Patterson brings over 20 years biotech CFO/CEO experience from Tenaya, Adverum, etc."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-184871","json":"https://secwatch.observer/filing/0001193125-24-184871.json","markdown":"https://secwatch.observer/filing/0001193125-24-184871.md","text":"https://secwatch.observer/filing/0001193125-24-184871.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1937653/000119312524184871/0001193125-24-184871-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1937653/000119312524184871/d810428d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T16:23:25.146589+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"13011efac1","claim":"Leone Patterson was appointed as Executive Vice President, Chief Business Officer and Chief Financial Officer at Zymeworks Inc..","evidence_excerpt":"On July 19, 2024, the Board of Directors (the “Board”) of Zymeworks Inc. (the “Company”) appointed Ms. Leone Patterson, age 61, as Executive Vice President, Chief Business Officer and Chief Financial Officer of the Company, effective upon her commencement of employment with the Company, which is anticipated to be September 1, 2024","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1937653/000119312524184871/0001193125-24-184871-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President, Chief Business Officer and Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}